Bixiye
QP35-26 Intensive Residential Treatment Services (IRTS) Prior Authorization (PA) Requirements
Taariikhda uu dhaqangalayo Barnaamijka: May 27, 2026
Natiijooyinka Raadinta
Soo bandhiga 4161 - 4170 ee natiijooyinka 4303
Bixiye
QP34-26 Billing Changes for Opioid Treatment Programs for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: May 27, 2026
Bixiye
Compounded Medications - Commercial
Formulary Exception, Coverage Exception
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026
Bixiye
Non-Preferred Drug with Continuation of Therapy - Medicaid
Oggolaanshaha Hore
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026
Bixiye
Pulmonary Arterial Hypertension - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026
Bixiye
Galafold (migalastat) - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026
Bixiye
Erythropoietins - Commercial
Oggolaanshaha Hore
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026
Bixiye
Leucovorin - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026
Bixiye
Substrate Reduction Therapy - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026
Bixiye
Cablivi (caplacixumab-yhdp) - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2026